Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.
Last trade$3.70
Day change-$0.14 (-3.65%)
Day range$3.67 – $4.10
Volume290,919
Market cap$217M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$217.05M
Price / earnings
—
Price / book
0.55×
Price / sales
0.12×
EV / sales
0.61×
EV / EBITDA
5.61×
Profitability
Earnings per share
-$0.57
Return on assets
-1.65%
Return on equity
-8.11%
Dividend yield
2.17%
Liquidity and leverage
Debt / equity
2.48×
Current ratio
1.06×
Quick ratio
0.65×
Cash ratio
0.11×
Cash flow
Price / cash flow
1.31×
Price / free cash flow
4.98×
Free cash flow
$43.6M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for OEC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$472.8M
$500.9M
$459.5M
$411.7M
$450.9M
$466.4M
$477.7M
$434.2M
Cost of revenue
$382M
$407.9M
$380.3M
$334M
$365.3M
$368M
$379.6M
$344.9M
Gross profit
$90.8M
$93M
$79.2M
$77.7M
$85.6M
$98.4M
$98.1M
$89.3M
Selling, general and administrative
$59.9M
$62.7M
$59.1M
$57.1M
$57.5M
$57.7M
$58.4M
$58.1M
Research and development
$4.9M
$7.2M
$7.3M
$7.5M
$6.9M
$6.5M
$6.6M
$7M
Total operating expenses
$68M
$71.7M
$67.8M
$64.2M
$139.3M
$66.3M
$66.9M
$63.7M
Operating income
$22.8M
$21.3M
$11.4M
$13.5M
-$53.7M
$32.1M
$31.2M
$25.6M
Interest expense
-$17.8M
-$16.3M
-$14.7M
$0
-$14.4M
-$19.1M
-$13.7M
$0
Income before taxes
$5M
$5.2M
-$3.2M
$2.8M
-$68.1M
$13.6M
$18M
$15M
Income taxes
$8.2M
$3.4M
$6.7M
$22.8M
-$500K
$4.6M
$8.9M
-$2.1M
Net income
-$3.1M
$1.8M
-$9.9M
-$19.5M
-$67.1M
$9M
$9.1M
$17.7M
Net income attributable to common shareholders
-$3.1M
$1.8M
-$9.9M
-$21.1M
-$67.1M
$9M
$9.1M
$17.2M
EBITDA
$62.4M
$54.2M
$44.1M
$41.3M
$60.8M
$64.1M
$62.7M
$120.2M
Basic earnings per share
-$0.05
$0.03
-$0.18
-$0.38
-$1.20
$0.16
$0.16
$0.30
Diluted earnings per share
-$0.05
$0.03
-$0.18
-$0.38
-$1.20
$0.16
$0.16
$0.31
Recent news
Company coverage with links to the original publishers.
Orion S.A. (OEC) is experiencing high implied volatility in its October 2026 put options, suggesting traders expect significant price movement. However, the fundamental outlook remains weak, with analysts downgrading earnings estimates for the current quarter from 7 cents to 5 cents per share over the last 60 days. The company holds a Zacks Rank #3 (Hold) rating in the Chemical - Specialty industry.
Orion (OEC) reported Q2 2026 adjusted earnings of 14 cents per share, beating consensus by 27.3%, with net sales rising 7.4% year-over-year to $500.9 million. However, shares have declined 21.5% since the earnings report. The Specialty Carbon Black segment showed strength with 96% EBITDA growth, while Rubber Carbon Black segment EBITDA fell 60.7% due to lower contractual pricing and softer tire production. The company reaffirmed its 2026 adjusted EBITDA guidance of $170-$210 million and raised free cash flow guidance. Analyst estimates have shifted downward 28.57% in the past month, and the stock holds a Zacks Rank #3 (Hold) with a VGM Score of B.
Orion reported Q1 2026 revenue of €417.7 million (+17.8% YoY) and operating profit of €114.8 million (+47.3% YoY). The company raised its 2026 guidance, expecting revenue of €1,950-2,100 million and operating profit of €600-750 million. Growth was driven by Nubeqa® royalties and product sales, Easyhaler® portfolio success, and strong performance across all business units. ODM-212 received FDA orphan drug designation for mesothelioma and initiated a Phase 1b/2 trial.
Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium on March 19, 2026, in Midtown Manhattan, featuring discussions with leading specialty chemicals companies on industry dynamics and trends. The event will include one-on-one meetings with management teams and webcast access for remote attendees.
Orion reported Q3 2025 net sales of €423.2 million and operating profit of €121.0 million, with growth in most business divisions. The company discontinued ODM-105 insomnia treatment and plans to focus on oncology research and biological candidates.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.0207 per share
Declared
Sep 17, 2026
Ex-dividend
Dec 11, 2026
Pay date
Jan 19, 2027
Ex-dividend
Amount / share
Pay date
Type
Jul 6, 2026
$0.0207
Oct 7, 2026
recurring
Jun 10, 2026
$0.0207
Jul 2, 2026
recurring
Mar 12, 2026
$0.0207
Apr 2, 2026
recurring
Dec 12, 2025
$0.0207
Jan 20, 2026
recurring
Jul 7, 2025
$0.0207
Oct 8, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.